announced its wholly-owned portfolio company Lucyd ltd has formed a reseller partnership with a Brazilian optical retailer and has conducted its first order.
“This is a unique opportunity for Lucyd to expand its eyeglass offerings into the large Brazilian market” said Tekcapital.
The distributor has purchased an initial order for 100 pairs of Lucyd Loud Bluetooth, bone-conducting glasses, which they will be selling on their own online eyewear store which will primarily serve Brazil, Mexico, Colombia and Chile.
The company’s Bluetooth audio smart glasses put Lucyd in a unique position to penetrate the growing online market for eyewear.
Shares in Tekcapital were trading at 7.75p each following the announcement
Clifford M. Gross Ph.D., Chief Executive Officer of Tekcapital plc said: “According to Statista, the online market for eyewear will deliver approximately $3.8b in sales in 2018”
“Lucyd has developed a very competitive footprint in this market with advanced eyewear to meet the needs of technological as well as fashion forward customers”
“We believe that Lucyd's unique features and products compare favorably with some of the most successful and respected names in the industry."
plc, is a UK intellectual property investment group focused on creating marketplace value from university technology.
Follow News & Updates fromhere:
Peter Webb, fund manager turned market commentator looks at PCF Group.
SP Angel morning look at commodities and miners, featuring: Anglo Asian Mining (AAZ LN) BUY – 96p (from 108p) – Earnings update Glencore (GLEN LN) – Glencore claim record EBITDA on strong copper mine performance Landore Resources (LND LN) – BAM Gold Preliminary Economic Assessment Pan African Resources (PAF LN) – Earnings climb as operations refocus on profitable ounces Transense Technologies plc (TRT LN) – 2nd mining contract announced this week for mining heavy truck tracking & tyre pressure monitoring
In a conference call to investors and analysts, Motif Bio confirmed that the FDA had no questions over the clinical efficacy of Iclaprim. However the FDA stated it needs additional data to further evaluate the risk for liver toxicity before the NDA approval.
Five financial stories, trending today in a 70 second podcast, including: The number of people in work in the UK has continued to climb, with a record 32.6 million employed between October and December The jobless rate, remaining at 4%, is at its lowest since early 1975.